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A B S T R A C T   
Background: Supplemental oxygen (O2) is used routinely during anesthesia. In the treatment of acute myocardial 
infarction, it has been established that hyperoxia is to be avoided, whereas information on benefit and risk of 
hyperoxia in patients with stable coronary artery disease (CAD) remain scarce, especially in the setting of general 
anesthesia. This study will compare the immediate effects of normoxemia and hyperoxia on cardiac function, 
with a primary focus on changes in peak longitudinal left-ventricular strain, in anesthetized stable chronic CAD 
patients using peri-operative transesophageal echocardiography (TEE). 
Methods: A single-center randomized cross-over clinical trial will be conducted, enrolling 106 patients under-
going elective coronary artery bypass graft surgery. After the induction of anesthesia and prior to the start of 
surgery, cardiac function will be assessed by 2D and 3D TEE. Images will be acquired at two different oxygen 
states for each patient in randomized order. The fraction of inspired oxygen (FIO2) will be titrated to a nor-
moxemic state (oxygen saturation of 95–98%) and adjusted to a hyperoxic state (FIO2 = 0.8). TEE images will be 
analyzed in a blinded manner for standard cardiac function and strain parameters. 
Conclusion: By using myocardial strain assessed by TEE, early and subtle signs of biventricular systolic and 
diastolic dysfunction can be promptly measured intraoperatively prior to the onset of severe signs of ischemia. 
The results may help anesthesiologists to better understand the effects of FIO2 on cardiac function and potentially 
tailor oxygen therapy to patients with CAD undergoing general anesthesia.   
1. Introduction 
1.1. Cardiac patients undergoing general anesthesia 
Ischemic heart disease is an increasingly prevalent disease. 
Approximately 30% of patients undergoing extensive non-cardiac sur-
gical procedures are at risk of or have diagnosed coronary artery disease 
(CAD) and a subsequent higher risk of perioperative cardiac complica-
tions [1]. Just the presence of cardiovascular disease places a patient 
higher on the perioperative risk score of the American Society of 
Anesthesiology (ASA), and increases perioperative mortality up to 
5–24% [2]. A significant cardiac complication is perioperative 
myocardial ischemia after non-cardiac surgery (MINS). MINS is still an 
ongoing concern in the professional community and is associated with 
increased postoperative mortality, even though most patients do not 
exhibit ischemic symptoms [3]. Anesthesia in combination with surgical 
trauma lead to a complex perioperative scenario exposing the heart to 
many stimuli. Hemodynamics can be affected by anesthetics and vaso-
active drugs [4], transitions from spontaneous to positive pressure 
ventilation, changes between normoxemia to hyperoxia, along with 
fluctuations in blood CO2 and hemoglobin concentration [5,6]. How-
ever, the relative contribution of anesthesia management to the 
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incidence of peri-operative outcomes has been notoriously difficult to 
quantify, since patients at risk are almost never exposed to general 
anesthesia (GA) without any surgery or intervention. Recently, more 
attention has been questioning the potential negative impact of iatro-
genic hyperoxia and if it is a contributor to peri-operative myocardial 
injury. 
1.2. Hyperoxia 
Adverse sequelae of hyperoxia may be caused by increased activity of 
reactive oxygen species, which directly impair tissue function and 
trigger subsequent cell death [7]. Other problems may arise owing to 
direct vasoconstrictive effects of hyperoxia [8,9]. Until recently a 
supranormal inspired oxygen fraction was perceived to improve safety 
margins in acute medical care, and its unrestricted use was ubiquitous. 
Hyperoxia was not perceived by medical staff to be detrimental, due to 
conflicting evidence with randomized clinical trials reporting both 
negative effects of hyperoxia or no impact [10–14]. More recently, the 
European Society of Cardiology has revised previous guidelines for ox-
ygen therapy in patients with acute coronary syndrome and recom-
mends supplemental oxygen in NSTEMI [15] and STEMI [16] only for 
patients with a peripheral oxygen saturation (SpO2) of less than 90% or 
in respiratory distress. Beyond acute cardiac care, there are various 
clinical scenarios, particularly in anesthesia and intensive care, where 
CAD patients may be exposed to supraphysiologic oxygen tensions, 
supporting the importance of further investigations. In the daily clinical 
practice, the arterial partial pressure of O2 always varies widely during 
different stages of GA and surgery and between physicians [17]. How-
ever, such increased inspired O2 concentrations during mechanical 
ventilation under GA often lead to supraphysiologic partial pressures of 
oxygen (paO2) in arterial blood. There is insufficient information on 
benefit and risk of such hyperoxia in patients with stable CAD, especially 
when undergoing GA with endotracheal intubation. 
We present a protocol for a new randomized cross-over clinical trial 
that will be conducted to investigate early functional surrogates of peri- 
operative myocardial ischemia during normoxemia and hyperoxia by 
echocardiographic strain analysis that may otherwise not be clinically 
apparent. 
2. Study design and methods 
2.1. Study design 
A single-center randomized cross-over study with blinded image 
analysis will be conducted at the Inselspital, Bern University Hospital in 
Switzerland. In total 106 patients undergoing an elective CABG surgery 
will be enrolled to undergo a standardized perioperative TEE exam at an 
inspired oxygen fraction (FIO2) of 0.3 with further adjustment to target a 
peripheral normoxemic oxygen saturation of 95–98% and 0.8 for 
hyperoxia after induction of GA and prior to the start of surgery. This 
trial was approved by the local ethics research board of Bern 
(2020–00145, April 2020), registered on clinicaltrials.gov 
(NCT04424433, first posted June 2020) and on the Swiss National 
Clinical Trials Portal (SNCTP000003911). The recruitment status will be 
posted regularly on clinicaltrials.gov. Informed consent will be obtained 
at least the day prior to surgery. The work carried out will comply with 
the Declaration of Helsinki. 
2.2. Study objectives 
The overall objective of this study is to investigate effects of iatro-
genic hyperoxia on myocardial function assessed by TEE in anesthetized 
patients with CAD prior to any surgical procedures. In particular, the 
primary aim of this study is to test the hypothesis if acute hyperoxia 
(FIO2 = 0.8) induced by and during general anesthesia leads to an 
attenuation in longitudinal peak systolic strain (%) as a measure of left- 
ventricular systolic function in comparison to normoxemia (SpO2 
95–98%). 
Secondary aims of this study are to assess differences in the impact of 
hyperoxia on other 2D and 3D systolic and diastolic strain parameters in 
comparison to traditional echocardiographic measures. Territorial 
strain discrepancies will also be compared between the healthy remote 
myocardium, myocardial territory subtended to previously revascular-
ized vessels (by percutaneous intervention, excluding patients with 
previous CABG surgery) and myocardial territories subtended to ste-
nosed vessel(s). Further aims are to identify patients at risk for 
hyperoxia-induced deterioration of strain parameters and association of 
such risk with baseline imaging measurements and demographic char-
acteristics, such as sex, age, ejection fraction, cardiac output and index, 
comorbidities and medication. 
2.3. Outcome measures 
The primary measured outcome with be the change in longitudinal 
peak systolic strain (%) measured between identical TEE image acqui-
sitions obtained in the same individual at normoxemia (SpO2 95–98%) 
and hyperoxia (FiO2 of 0.8). 
Secondary outcome measures include the acquisition of the 
remaining TEE 2D and 3D systolic and diastolic strain parameters (i.e. 
time to peak strain, systolic and diastolic strain rates, displacements, 
velocities, torsion) and traditional TEE measures as well such as ven-
tricular volumetry and function, stroke volume derived from the ve-
locity time integral of the left ventricular outflow tract, tissue doppler 
and mitral valve inflow patterns to assess diastolic function, right ven-
tricular fractional area change and tricuspid annular plane systolic 
excursion (detailed in Fig. 2). Anesthesia and hemodynamic parameters 
along with patient characteristics will also be collected. 
2.4. Study population 
In this study we will prospectively recruit patients scheduled for 
elective CABG surgery with angiographically documented coronary 
status, who will undergo general anesthesia and clinically indicated 
intra-operative TEE evaluation (Table 1). The patient population of the 
proposed study is ideally suited to answer this question, because a) the 
coronary status of these patients has been defined, b) these patients are 
routinely exposed to a variety of oxygen levels during induction and 
anesthesia for their coronary surgery, and c) they are undergoing indi-
cated invasive hemodynamic, blood gas and TEE monitoring. 
Table 1 
Eligibility criteria.  
Inclusion Criteria  
• Elective coronary artery bypass graft (CABG) surgery  
• Ability to provide informed consent  
• Age > 18 years 
Exclusion Criteria  
• Absolute contraindication for TEE  
• Emergency surgery, including but not limited to patients with unstable CAD: ST- 
and Non-ST-elevation myocardial infarction (STEMI, NSTEMI) and unstable angina  
• Atrial fibrillation or significant arrhythmia  
• Pacemaker, cardiac resynchronization therapy, left bundle branch block  
• Severe-grade valvular disease  
• Pericardial disease  
• Previous cardiac or thoracic aortic surgery  
• Previous chest radiation therapy, cardiotoxic or bleomycine chemotherapy  
• Severe pulmonary hypertension, cor pulmonale, or right ventricular dysfunction, i. 
e., where high FIO2 might reduce pulmonary vascular resistance and right 
ventricular afterload.  
• Patients where study explanation and informed consent cannot be performed/ 
obtained at the latest on the day before scheduled surgery.  
• Females of child-bearing potential.  
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2.5. Sample size 
As similar data investigating the impact of hyperoxia on myocardial 
strain in a GA environment has not been published, sample size is based 
off magnetic resonance imaging results in awake CAD patients [18]. An 
a priori conducted sample size analysis calculated 91 individuals would 
have an 80.1% power to reject the null-hypothesis with an effect size of 
0.3 (based on a difference of 0.3 ± 1.0%) and a level of significance 
(alpha) of 0.05 with a two-sided general linear model with equal vari-
ance. We expect up to 15 subjects could be associated with premature 
dropouts, anatomical limitations to the TEE probe, or severe imaging 
artefacts and general bad image quality in which a full dataset cannot be 
analyzed. Therefore, 106 patients will be enrolled into the study. 
2.6. Randomization protocol 
In this crossover design, patients will be assigned to either a 
normoxemia-first (N) or a hyperoxia-first (H) on the day of surgery using 
a randomization procedure. The respective allocation will determine 
which oxygen level will be evaluated by TEE first, after which the other 
level will be assessed. No specific restrictions will be applied to the 
randomization, and the randomization procedure will occur in batches 
using a concealed envelope with the order of envelopes determined by a 
computer-generated algorithm. The anesthetist who acquires the TEE 
images will be aware of the randomization in order to target the gas 
levels and provide proper anesthetic management for the patient. The 
patient will not be aware of his/her group allocation, nor will the reader 
who analyzes coded images after the surgery. 
2.7. Induction of GA 
Patients will arrive at the operating room for their scheduled surgery. 
A finger pulse oximeter able to determine the oxygen reserve index (ORi, 
Radical®7, Masimo Inc.) will be mounted and monitored throughout 
induction and the study. Baseline SpO2 and ORi will be noted at room air 
for comparison of the normoxemic state during the study induction. 
Induction of GA is performed according to standardized institutional 
guidelines. After arrival of the patient in the preparation area 1 mg of 
midazolam will be administered prior to placement of the arterial line. 
Prior to induction, patients will then be preoxygenated with 100% ox-
ygen according to institutional and internationally accepted safety 
standards. A sufentanil bolus (0.5 μg/kg) will be administered during 
pre‑oxygenation. At an end-tidal expiratory FetO2 ≥ 0.8, the induction 
dose of 1-2 mg/kg propofol will be carefully titrated to reach anesthesia 
depth sufficient for intubation. Rocuronium (1 mg/kg) is used for muscle 
relaxation in all patients, after which endotracheal intubation is per-
formed. After intubation, FiO2 will then be adjusted to 0.8 and after 5 
min of steady state SpO2 and ORi will be recorded as a final baseline 
measure. Anesthesia will be maintained with inhalation of Isoflurane 
and continuous infusion of sufentanil (10–20 μg/kg/h). Appropriate 
dosing of anesthetics and vasopressor support by norepinephrine (goal 
of mean arterial pressure > 65 mmHg) are at the discretion of the 
attending anesthesiologist. Placement of all necessary central lines will 
occur, and the TEE probe will be inserted. Time from induction to 
acquisition of the first study images will be approximately thirty mi-
nutes. Afterwards, the study specific protocol will be performed prior to 
any surgical stimulus. 
2.8. Study intervention 
During the study intervention under GA, positive end-expiratory 
pressure (PEEP) is set at a minimum of 5 mmHg, tidal volume set at 6- 
8 ml/kg per normal predicted bodyweight, with ventilation rate set to 
maintain a normal end-expiratory CO2 (35-40 mmHg), and then further 
adjusted if required. Based on the randomization protocol (Fig. 1), either 
normoxemia (Group N) or hyperoxia (Group H) will be targeted first, 
followed by the remaining gas level.  
• Group N: FIO2 will be initially reduced to 0.3 and further titrated 
until ORi returns to 0 and SpO2 ranges from 95 to 98% to ensure 
normoxemia. If an FIO2 of 0.3 yields a SpO2 > 98% FIO2 may be 
further reduced to 0.25. If an FIO2 of 0.3 will results in an SpO2 <
95% lung recruitment maneuvers will be performed, followed by a 
stepwise increase in PEEP to a maximum of 8 mmHg before FIO2 is 
allowed to be further increased in 0.05 increments to target nor-
moxemic SpO2. Continuous SpO2 and ORi readings will be monitored 
to confirm a stable blood gas level has been reached. After 5 min of 
steady-state FIO2 and maintaining target readings of SpO2 and ORi, 
arterial oxygen saturation and paO2 will be confirmed with an 
arterial blood gas analysis, and all pertinent imaging will be obtained 
(Fig. 2). FIO2 will then be increased to 0.8 to target hyperoxia as the 
second level. The resultant ORi and will be monitored to confirm 
stabilization, and hyperoxia will be confirmed by arterial blood gas 
analysis after 5 min of steady state. TEE acquisition will then be 
repeated identically to the acquisition at normoxemia.  
• Group H: Procedures targeting gas levels will be the same as 
described for group 1 (N), however in the case of the second group, 
the hyperoxic level will be targeted first after the induction. After 
data acquisition, FIO2 will be reduced to target normoxemia as the 
second level. 
Fig. 1. Study Pathway. 
Transesophageal echocardiography (TEE) images will be acquired at both an 
inspired fraction of oxygen (FIO2) of initially 0.3 with further adjust to target 
SpO2 of 95–98% if necessary and 0.8 in the time frame between induction and 
the start of surgery. Patients will be randomized to receive normoxemia (N, 
FIO2 = 0.3) first, or hyperoxia first (H, FIO2 = 0.8). 
Fig. 2. Transesophageal Echocardiography. 
A. Right ventricular 3D cine, B. Left ventricular 3D cine, C. Septal tissue doppler 
velocity, D. Lateral wall tissue doppler velocity. E. Right ventricular centered 4- 
chamber cine, F. Left ventricular centered 4-chamber cine, G. 2-chamber cine, 
H. 3-chamber cine/long axis view, I. short-axis cine (acquired in 3 planes), J. 
Tricuspid annular plane systolic excursion using anatomic M-Mode, K. Mitral 
inflow, L. Left ventricular outflow tract velocity time integral. 
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Once images and data measurements are acquired from the second 
level, the participant has completed the study protocol. The expected 
time of the experimental procedure is approximately up to 25 min. 
Thereafter FIO2 is selected at the discretion of the attending anesthesi-
ologist and normal clinical routine and surgery will begin. 
2.9. Image acquisition protocol 
All images are acquired intra-operatively by cardiovascular anes-
thesiologists certified in TEE by the European Association of Cardio-
vascular Imaging (EACVI) and European Association of Cardiothoracic 
Anesthesiology and Intensive Care (EACTAIC) with Philips EPIQ 7c (X7- 
2t probe) or EPIQ CVx (X8-2t probe, EPIQ ultrasound system, Philips 
Medical Systems, Andover, USA), while hemodynamic readings and 
blood gases are stable as monitored by SpO2, ORi and confirmed by 
arterial blood gas analysis. Standard two-dimensional (2D) data will be 
acquired to measure biventricular systolic and diastolic function. This 
includes mid-esophageal left and right ventricular centered 4-chamber 
views, 2-chamber, long-axis 3-chamber; and trans-gastric basal, mid- 
ventricular and apical short-axis views. Tricuspid annular plane sys-
tolic excursion will be acquired using anatomical M-Mode from the right 
cantered 4-chamber view or with conventional M-Mode from the deep 
trans-gastric view. Diastolic function will be assessed by acquiring tissue 
doppler imaging velocities of the septal and lateral mitral valve insertion 
points, together with the mitral inflow pattern using pulsed wave 
doppler. In addition, left ventricular stroke volume will be assessed by 
velocity time integral measurements in the left ventricular outflow tract 
from a trans-gastric long-axis view or a deep trans-gastric 4-chamber 
view. Additionally, a 3D cine volume (6 beats during apnea) of the 
left and right ventricle will be acquired for subsequent analysis of 3D 
strain and volumetry (Fig. 2). This imaging protocol is acquired at each 
gas level. 
2.10. Monitoring safety outcomes 
As described in the section Study Intervention, FiO2 and SpO2 are used 
to target normoxemia. We will also obtain blood gas analysis to measure 
paO2 levels as a third measure to monitor safety thresholds. As a safety 
margin, a paO2 of 80 mmHg will be considered a lower threshold for the 
normoxemia level at which corrective action to increase paO2 will be 
taken. Lower paO2 levels <60 mmHg during normoxemia will be 
considered an adverse event. PaO2 levels at or above 60 mmHg is 
considered normal for the typical age range of the target patient popu-
lation [19]. Vital parameters will be monitored and recorded continu-
ously. This includes heart rate, 5‑lead electrocardiogram, respiratory 
mechanics and inspiratory and expiratory end-tidal gas analysis for O2 
and CO2, SpO2 and ORi, processed electroencephalogram parameters, 
invasive arterial pressures, arterial blood gas analysis and oximetry. 
Signs or symptoms of new-onset acute myocardial ischemia during study 
interventions will be monitored and recorded. This includes, for 
instance, new hemodynamic instability, significant ST-elevation or 
depression, new-onset severe wall motion abnormality in >2 segments. 
If these events occur during the study, the current blood gas level will be 
aborted, and the previous more stable gas level will immediately re- 
installed. 
2.11. Data analysis 
Tricuspid annular plane systolic excursion, septal and lateral tissue 
doppler velocities, E (early component) and A (atrial component) mitral 
influx velocities using pulsed wave doppler and left ventricular outflow 
tract velocity time integral will be analyzed on the echocardiography 
machine right after completion of the study intervention for both blood 
gas levels. 
For the remaining assessments readers will be blinded to both patient 
identity and medical history, along with the oxygen level. All TEE image 
datasets at normoxemia and hyperoxia will be analyzed in batches a 
period of time after the surgery using clinically validated software 
(TomTec-Arena, TomTec Imaging Systems, Unterschleissheim, Ger-
many). Analysis will include measures of biventricular volumetry and 
ejection fraction from 3D datasets, left ventricular ejection fraction from 
the 2D 4-chamber and 2-chamber views using the Simpson method of 
discs as well as right ventricular fractional area change from the right 
ventricular centered 4-chamber view. For both 2D and 3D acquisitions, 
systolic as well as diastolic global and segmental longitudinal, radial and 
circumferential strain parameters will be analyzed (Fig. 3). Strain 
measurements will be acquired for global measures of both ventricles. 
The primary measured parameter will be global longitudinal left- 
ventricular peak systolic strain. Moreover, parameters of the left 
ventricle will be further reported for regional analysis by using the 
myocardial American Heart Association (AHA) 16 segment model. After 
unblinding, these segments will then be categorized as post-stenotic, 
reperfused or remote territory based on the status of the perfusing cor-
onary artery according to coronary angiography report. Coronary le-
sions visually assessed with a diameter stenosis greater than 50% will be 
localized to the corresponding segment of the coronary artery and 
classified as proximal, mid, distal or in a subsequent branch. Based on 
the pattern of coronary dominance the allocation of myocardial seg-
ments will follow Fig. 4. Data will then be matched to the gas level and 
analyzed according to the primary and secondary outcomes. Further 
arterial blood gases, ORi, heart rate, blood pressure and other anesthetic 
measurements at the time of image acquisition as well as coronary sta-
tus, demographic data, medication and comorbidities will be obtained 
for statistical analysis. 
Interobserver variability will be assessed with 20 datasets to 
compare the readings of the anesthesiology study team with a collabo-
rator from cardiology experienced with 2D and 3D strain analysis. 
2.12. Statistical analysis 
Continuous variables will be reported as mean and standard devia-
tion or median with interquartile ranges, while categorical variables are 
reported as frequency and percentages. 
For the primary endpoint, to investigate if there is a difference in 
global peak longitudinal strain between normoxemia and hyperoxia, a 
mixed effects general linear model will be used that includes the ran-
domized group category as a variable to account for any possible order 
effect with the gas levels. Inclusion for significant covariates will be 
made if appropriate. 
Fig. 3. Myocardial Strain Analysis. 
A. Left ventricular longitudinal strain from a 3D TEE image with segmental 
strain curves in the lower panel. B. 2D right ventricular global longitudinal peak 
strain and ventricular area and area change over time. 
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Secondary endpoints investigating changes in other echocardio-
graphic parameters between gas levels will be assessed with similar 
statistical models as the primary endpoint. 
Post-hoc analysis accounting for multiple comparisons within pa-
tient myocardium will be applied to investigate the changes in regional 
strain across the myocardium. General linear models will be used to 
investigate the association of pre-operative or baseline values with a 
change in strain due to hyperoxia, and receiver operating characteristic 
curves will be used for the determination of cut-off values if appropriate. 
For interobserver and intraobserver reproducibility, reliability will 
be determined with an intra-class correlation (ICC) for absolute agree-
ment. Agreement between reads will be further tested with Bland- 
Altman analysis for the mean bias and 95% limits of agreement. 
In the case of non-normal distribution, non-parametric tests will be 
applied if applicable. Statistical significance is defined with a two-sided 
p-value of <0.05. GraphPad Prism version (GraphPad Software, La Jolla 
California USA), and IBM SPSS Statistics 26 (IBM, Armonk, NY, USA) are 
planned to be used for analysis. 
3. Discussion 
3.1. Oxygen dose rational 
In this study we use FIO2 to target the oxygen levels (0.3 and 0.8), 
guided by SpO2 and ORi. Except for induction of general anesthesia, 
there is no consensus on mandatory perioperative hyperoxygenation in 
patients with stable CAD, nor for during maintenance of general anes-
thesia in a general patient population. In 2017 the WHO stipulated that 
FIO2 should be set to 0.80 in all adults undergoing endotracheal general 
anesthesia, in order to reduce the incidence of surgical site infection 
[20]. These recommendations have been disputed by experts in the 
fields of anesthesiology and critical care medicine, and remain contro-
versial [21]. Since high-quality evidence is lacking for a beneficial effect 
of a FIO2 of 0.60 or higher on surgical site infection, Wetterslev et al. and 
the Cochrane Anesthesia Group performed a meta-analysis in 2015 on 
the effects of perioperative inspiratory oxygen fraction in adult surgical 
patients. They came to the conclusion that there was insufficient evi-
dence to support the routine use of a high FIO2 (0.6 to 0.9) beyond what 
is needed to maintain normal arterial oxygen saturation (generally 0.3 to 
0.4) [22]. A survey showed that anesthesiologists feel that a safe FIO2 for 
their patients ranges between 0.40 and 0.60 [17,23]. Thus, current FIO2 
dosing practice is rather eminence- than evidence-based. 
The FIO2 levels selected in this study proposal lie within existing 
clinical recommendations, and safe oxygenation levels will be moni-
tored using continuous pulse oximetry and ORi, which can detect 
imminent deoxygenation 30s before it becomes apparent in SpO2 
monitoring [24]. In this regard, our protocol is in close accordance with 
the published multi-center PROXI trial [14]. These FIO2 targets are also 
similar to other ongoing trials investigating other peri and post- 
operative outcomes in relation to hyperoxia (NCT04808401, 
NCT03388957 [25], NCT03494387 [26]). 
3.2. Advantages of myocardial strain 
While several hyperoxia studies focus on outcome or serum markers, 
which may take a few hours to develop from the onset of myocardial 
insult, this study will implement strain analysis on peri-operative images 
as a novel assessment to investigate the immediate impact of peri- 
operative hyperoxia on cardiac function. In various cohorts strain able 
to detect subtle myocardial dysfunction and is an incremental prognostic 
marker beyond traditional measurements such as ejection fraction 
[27–29], and is increasingly incorporated as a key endpoint for clinical 
trials [30,31]. Systolic and diastolic function parameters can be assessed 
in longitudinal, circumferential and radial orientation, thus providing 
information on the different layers of the myocardium. What is also 
another benefit of strain beyond ejection fraction and volumetry is that 
it quantifies regional dysfunction. This is particularly beneficial in the 
case of our CAD population where myocardium downstream of signifi-
cant epicardial lesions may be more at risk to ischemic events. Discor-
dance in myocardial function caused by underlying infarct or inducible 
ischemia can lead to post-systolic shortening [32] and a widespread 
mechanical dispersion [33]. Moreover we will incorporate both 2D and 
3D imaging. While 2D is the universal application, 3D is a developing 
field as it provides comprehensive coverage of the heart, and can be 
rapidly acquired, generally using 6-heart beats to provide sufficient 
temporal resolution. 
While there are currently multiple publications assessing the diag-
nostic use of strain in a non-anesthesia setting, there are many benefits 
of peri-operative assessments of myocardial deformation as well 
detailed in a review by Duncan et al. [34]. In this study strain is analyzed 
outside of the operating room, so that analysis can be blinded and per-
formed in batches, thus removing any analyzers bias. Nevertheless, 
strain analysis is also feasible intra-operatively to get an assessment of 
current myocardial function. Perioperative changes in both left ven-
tricular [35,36] and right ventricular strain [37] are now reported to 
Fig. 4. Allocating Coronary Angiogram Findings to Myocardial Strain. 
A. Locations of epicardial stenoses will be allocated to the coronary tree seg-
ments for the right coronary artery (RCA, blue), left anterior descending (LAD, 
yellow) and left circumflex (LCx, green) coronary artery. B. According to the 
coronary dominance, the myocardial American Heart Association (AHA) seg-
ments will be matched to the coronary tree segments, with lesions in the 
proximal portion of the coronary artery (dark shading) impacting the basal 
segments and downstream myocardium. Lesions in the distal portion of the 
coronary artery (light shading) will impact only apical segments, while striped 
segments represent perfusion by the diagonal and marginal branches. C. 
Myocardial AHA segments are shown on a strain overlay from a 3D left ven-
tricular acquisition. 
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depict the development of peri-operative myocardial dysfunction, even 
in cases when changes in ejection fraction are not noted. Thus, we 
propose that the ability of strain to detect subtle dysfunction may shed 
more light on the inconclusive findings of the impact of hyperoxia on 
cardiac function during general anesthesia. 
3.3. Added relevance to reported studies of peri-operative hyperoxia 
As the awareness of potential detrimental effects of supplemental O2 
arise, there is still conflicting evidence about the perioperative effects of 
hyperoxia in patients undergoing GA between studies and within a study 
population itself. Peri-operative and post-operative studies investigating 
hyperoxia have initially focused on surgical site infections, where 
hyperoxia was reported to be beneficial for some procedures, whereas 
more recent findings are inconclusive or show no difference related to 
oxygen fraction [38,39]. Similarly, inconclusive results have been 
observed with pulmonary complications as a cause of hyperoxia 
[40–42]. A few published anesthesia trials have also focused on long- 
term cardiac specific or overall survival outcomes. During CABG, a 
randomized control trial reported there was no difference in serum 
markers or hypoxic events between groups maintained at a paO2 target 
of 200-220 mmHg versus 120-150 mmHg during cardiopulmonary 
bypass [43]. However, it has to be noted that the difference between 
both oxygen levels is small and the lower paO2 group had already mild 
hyperoxic paO2. After abdominal surgery, the Danish PROXI trial, found 
an increase in long-term mortality after exposure to perioperative 
hyperoxia [44]. In addition, further analysis of the PROXI trial described 
an increased incidence of new acute coronary syndrome and long term 
risk of myocardial infarction in the FIO2 group of 0.80 vs 0.30 group 
[45]. Two randomized clinical trials (HOT-ICU and ICU-ROX) have 
investigated even lower oxygen targets in patients with acute hypoxemic 
respiratory failure in the intensive care unit, and found adverse events 
were the same when targeting conservative oxygen targets of a paO2 of 
60 mmHg or maximal SpO2 of 90% in comparison to paO2 of 90 mmHg 
or SpO2 of 97% respectively [42,46]. However, investigating markers 
that don’t arise until a period of time after oxygen administration 
doesn’t provide information on the direct cause and effect relationship 
as perioperative anemia, hypotension and postoperative distress with 
tachycardia from pain may also result in ischemia. The added relevance 
of our proposed study to the current literature is that it will investigate 
the peri-operative impact of hyperoxia and assess if there is an imme-
diate impact of the FiO2 level on biventricular function. The intent is to 
investigate if subtle dysfunction occurs, especially prior to the devel-
opment of severe symptoms of ischemia that may lead to increased 
morbidity and mortality. 
Utilizing invasive measures and cardiac magnetic resonance imaging 
in an anesthetized swine model with an acutely induced significant 
coronary artery stenosis we have previously reported hyperoxia (paO2 
> 300 mmHg) decreased coronary flow, consequently impairing both 
regional myocardial oxygenation and wall motion measured by strain 
analysis in the myocardium distal to the stenosis [9]. In a non-anesthesia 
setting, independent groups reported inhaling O2 for 20 min compro-
mised cardiac output and other hemodynamic measures in awake heart 
failure patients [47]. Using more advanced imaging modalities, 
myocardial perfusion and cardiac output also decreased in healthy 
controls breathing supplemental oxygen [48]. Similarly we have pre-
viously investigated the immediate impact of hyperoxia in awake pa-
tients with stable CAD, and there was no global benefit or impairment in 
the acute response to hyperoxia when investigating systolic markers 
such as ejection fraction and peak strain using magnetic resonance [18]. 
However, when patients had underlying myocardial injury as shown by 
myocardial tissue characterization, or if they had compromised 
myocardial strain at baseline, these patients developed a myocardial 
oxygenation heterogeneity and subsequent reduction in myocardial 
function after a brief period of O2 [18]. Moreover many studies focus on 
systolic measures, yet we observed a significant decrease in diastolic 
function in the awake CAD group [18]. While the focus on myocardial 
function is primarily on systolic function, diastolic function may play an 
important role, especially as it is earlier in the ischemic pathway, and 
should theoretically arise prior to overt systolic abnormalities and more 
severe signs of myocardial injury including ST elevations and rises in 
serology markers such as troponins [49]. However, these human studies 
investigated awake participants without the complex environment 
associated with GA, and it is unknown if the same findings may be 
observed. 
4. Conclusion & rationale for the study 
Existing recommendations on appropriate intraoperative oxygena-
tion targets during general endotracheal anesthesia are aimed at pre-
vention of surgical site infections [50]. Evidence regarding other 
benefits or adverse effects of iatrogenic hyperoxia during general 
anesthesia in patients with known heart disease is minimal, with current 
publications relying on various outcomes that often arise post-surgery. 
Using TEE-based strain analysis, we will be able to detect early signs 
of myocardial ischemia during the perioperative period and determine 
whether the worsening of myocardial function occurs significantly more 
frequently during controlled intraoperative hyperoxia. Although this 
study investigates patients undergoing CABG surgery, all study in-
terventions are performed prior to the start of any surgical procedure, 
thus these findings are relevant to patients with CAD undergoing general 
anesthesia for all types of cardiac surgery. Moreover, as the confounding 
effects associated with surgery will not impact the results, these findings 
will primarily demonstrate the impact of factors associated with anes-
thetic procedures. Thus, this study may show if perioperative hyperoxia 
is one of the puzzle pieces leading to myocardial injury during general 
anesthesia and may help anesthesiologists to better weigh risks and 
benefits when selecting an inspired oxygen fraction. 
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